Inventor · disambiguated record
Jens Juul Holst
Also filed as: HOLST JENS J · HOLST JENS JUUL
9 granted patents·10 pending applications·238 citations·filing 1997–2021
88Inventor score
Files withUNIV COPENHAGEN6NOVO NORDISK AS5SANOS BIOSCIENCE AS4AMYLIN PHARMACEUTICALS INC1HANSEN HARALD S1
Top patents by PatentIndex Score
19 records- 0195US7371721B2Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromesSANOS BIOSCIENCE AS·Filed 2005·Granted May 13, 2008·39 cites·16 claims
- 0293US7186683B2Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disordersSANOS BIOSCIENCE AS·Filed 2003·Granted Mar 6, 2007·59 cites·10 claims
- 0389US5912229AUse of a pharmaceutical composition comprising an appetite-suppressing peptideNOVO NORDISK AS·Filed 1997·Granted Jun 15, 1999·112 cites·17 claims
- 0482US6884579B2GLP-1 as a diagnostic test to determine β-cell function and the presence of the condition of IGT and type-II diabetesAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Apr 26, 2005·16 cites·12 claims
- 0581US10774127B2Peptide dual agonists of GIPR and GLP2RUNIV COPENHAGEN·Filed 2017·Granted Sep 15, 2020·3 cites·20 claims
- 0675US11572399B2Long-acting GIP peptide analoguesUNIV COPENHAGEN·Filed 2018·Granted Feb 7, 2023·2 cites·23 claims
- 0774US6943151B2Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compoundsSANOS BIOSCIENCE AS·Filed 2003·Granted Sep 13, 2005·7 cites·22 claims
- 0864US2009149387A1Use of GLP-1 PeptidesNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 0959US2007161568A1Use of GLP-1 peptidesNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1056US11725037B2Peptide dual agonists of GIPR and GLP2RUNIV COPENHAGEN·Filed 2020·Granted Aug 15, 2023·0 cites·19 claims
- 1155US2007135345A1Use of GLP-2 for the treatment or prevention, of bone-related disordersHENRIKSEN DENNIS B·Filed 2006·Application pending·0 cites
- 1252US2011028391A1Use of GLP-1 PeptidesNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 1352US2003232754A1Use of GLP-1 peptidesFiled 2003·Application pending·0 cites
- 1451US2021340211A1Gip peptide analoguesUNIV COPENHAGEN·Filed 2021·Application pending·0 cites
- 1551US2010113363A1Use of GLP-1 PeptidesNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 1647US2008249016A1Use of GLP-2 in a combination treatment for bone-related disordersSANOS BIOSCIENCE AS·Filed 2008·Application pending·0 cites
- 1741US10968266B2GIP peptide analoguesUNIV COPENHAGEN·Filed 2015·Granted Apr 6, 2021·0 cites·18 claims
- 1838US2020261543A1Combination therapy for treatment of bone disordersUNIV COPENHAGEN·Filed 2018·Application pending·0 cites
- 1932US2012128770A1Treatment of insulin resistance and obesity by stimulating glp-1 releaseHANSEN HARALD S·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jens Juul Holst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →